基于量子点CdSe两次给药PDT体外灭活HL60的最佳参数实验研究

洪旭亮; 王健; 陈丽; 林柏瀚; 熊建文

doi:doi:10.3969/j.issn.1007-7146.2013.05.005

激光生物学报, 2013, 22 (5): 416, 网络出版: 2015-07-23

基于量子点CdSe两次给药PDT体外灭活HL60的最佳参数实验研究

The Optimal Parameter of vitro Inactivation on Leukemic HL60 Cells by Double Drug Delivery of CdSe Quantum Dots Based on Photodynamic Therapy

论文大纲

洪旭亮 ^1,*王健 ¹陈丽 ²林柏瀚 ¹熊建文 ¹

作者单位

¹ 广东省高等学校量子信息技术重点实验室, 华南师范大学物理与电信工程学院, 广东广州510006

² 广东工业大学物理与光电工程学院, 广东广州 510006

摘要

光漂白是光动力疗法(Photodynamic therapy, PDT)中的一个伴随过程, 其存在会影响光敏剂的光敏性能并消耗光敏剂。初步探讨了基于量子点CdSe的光动力疗法中两次给药的问题、给药最佳时间间隔、二次给药的最佳作用参数及正常的与药物处理过的白血病HL60细胞表面的超微结构变化。实验表明, 一次给药在量子点浓度为1.0 μmol/L且18 J/cm2的光剂量作用下, PDT效率达到61.0%; 经过48 h后, 进行二次给药, 在量子点浓度为0.75 μmol/L, 18 J/cm2光剂量作用下, PDT效率达到了72.1%, 较一次给药有了较大幅度提升; 扫描电子显微镜(SEM)观察药物作用前后的白血病HL60细胞表面超微结构, 结果显示, 细胞表面发生了一些显著的变化, 由此推测细胞膜可能是量子点CdSe介导的光动力疗法(CdSe-PDT)灭活白血病HL60细胞的一个重要突破口; 最后对量子点CdSe光致毒性的机制进行了初步探讨。

Abstract

The concentration of photosensitizer may be reduced and the photosensitive properties could be affected during the photodynamic therapy with a coinstantaneous process which is known as photobleaching. The optimal parameter of vitro inactivation on Leukemic HL60 by double drug delivery, the best time interval between the first and second drug delivery and the ultrastructural morphology of treated and untreated HL60 cells, based on Photodynamic Therapy(PDT) are investigated. The results show that the PDT efficiency could achieve 61.0% for the first drug delivery with the concentration of 1.0 μmol/L and irradiation dosage of 18 J/cm2 . After 48 hours, the second drug deliver is carried out. When the final concentration of CdSe is at 0.75 μmol/L, the PDT efficiency is up to 72.1% with the irradiation dosage of 18 J/cm2. The ultrastructural morphology of the treated and untreated HL60 cells are observed by scanning electron microscope(SEM). The experimental results indicate that significant change occurred, which may be a convincing evidence that cytomembrane is a probable target in Leukemic HL60 cells destruction using CdSe-PDT. A possible mechanism of photoinduced toxicity of CdSe quantum dots is proposed.

参考文献

[1] WEN L Y, BAE S M, CHUN H J, et al. Therapeutic effects of systemic photodynamic therapy in a leukemia animal model using A20 cells［J］. Lasers in Medical Science, 2012, 27(2): 445-452.

[2] NYMAN E S, HYNNINEN P H. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy［J］. Journal of Photochemistry and Photobiology B: Biology, 2004, 73(1): 1-28.

[3] DOUGHERTY T J, GOMER C J, HENDERSON B W, et al. Photodynamic therapy［J］. Journal of the National Cancer Institute, 1998, 90(12): 889-905.

[4] DE BRUIJN H S, SLUITER W, DER PLOEG-VAN DEN HEUVEL V, et al. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy［J］. Photodermatology, Photoimmunology & Photomedicine, 2006, 22(5): 238-246.

[5] WILSON B C, PATTERSON M S, LILGE L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm［J］. Lasers in Medical Science, 1997, 12(3): 182-199.

[6] BAKALOVA R, OHBA H, ZHELEV Z, et al. Quantum dot anti-CD conjugates: are they potential photosensitizers or potentiators of classical photosensitizing agents in photodynamic therapy of cancer ［J］. Nano Letters, 2004, 4(9): 1567-1573.

[7] SAMIA A, DAYAL S, BURDA C. Quantum Dot-based energy transfer: perspectives and potential for applications in photodynamic therapy［J］. Photochemistry and Photobiology, 2006, 82(3): 617-625.

[8] BAKALOVA R, OHBA H, ZHELEV Z, et al. Quantum Dots as Photosensitizers ［J］. Nature Biotechnology, 2004, 22(11): 1360-1361.

[9] UZDENSKY A B, IANI V, MA L W, et al. Photobleaching of Hypericin Bound to Human Serum Albumin, Cultured Adenocarcinoma Cells and Nude Mice Skin［J］. Photochemistry and Photobiology, 2002, 76(3): 320-328.

[10] BONNETT R, MARTINEZ G. Photobleaching of sensitisers used in photodynamic therapy［J］. Tetrahedron, 2001, 57(47): 9513-9547.

[11] 顾瑛, 刘凡光. 光动力疗法［M］. 北京: 人民卫生出版社, 2004: 10-11.

GU Ying, LIU Fanguang. Photodynamic Therapy［M］. Beijing: People’s Medical Publishing House, 2004: 10-11.

[12] CHEKULAYEVA L V, CHEKULAYEV V A, SHEVCHUK I N. Active oxygen intermediates in the degradation of hematoporphyrin derivative in tumor cells subjected to photodynamic therapy［J］. Journal of Photochemistry and Photobiology B: Biology, 2008, 93(2): 94-107.

[13] TOMINAGA H, ISHIYAMA M, OHSETO F, et al. A water-soluble tetrazolium salt useful for colorimetric cell viability assay［J］. Anal Commun, 1999, 36(2): 47-50.

[14] 熊建文, 肖化, 张镇西. MTT 法和 CCK-8 法检测细胞活性之测试条件比较［J］. 激光生物学报, 2007, 16(5): 559-562.

XIONG Jjianwen, XIAO Hua, ZHANG Zhengxi. An experimental research on different detection conditions between MTT and CCK-8［J］. Acta Laser Biology Sinica, 2007, 16(5): 559-562.

[15] LOVRIC＇J, CHO S J, WINNIK F M, et al. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death［J］. Chemistry & Biology, 2005, 12(11): 1227-1234.

[16] TSAY J M, MICHALET X. New light on quantum dot cytotoxicity［J］. Chemistry & Biology, 2005, 12(11): 1159-1161.

[17] JUZENAS P, CHEN W, SUN Y P, et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer［J］. Advanced Drug Delivery Reviews, 2008, 60(15): 1600-1614.

[18] SHI C, ZHU Y, CERWINKA W H, et al. Quantum dots: emerging applications in urologic oncology［J］. Urologic Oncology: Seminars and Original Investigations, 2008, 26(1): 86-92.

[19] 刘庆华, 余亮, 熊建文. 在光动力疗法中应用的量子点［J］. 激光生物学报, 2008, 17(1): 138-143.

LIU Qinghua, YU Liang, XIONG Jianwen. Quantum dots applied in photodynamic therapy［J］. Acta Laser Biology Sinica, 2008, 17(1): 138-143.

[20] SMITH A M, DUAN H, MOHS A M, et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging［J］. Advanced Drug Delivery Reviews, 2008, 60(11): 1226-1240.

[21] CHATTERJEE D K, FONG L S, ZHANG Y. Nanoparticles in photodynamic therapy: an emerging paradigm［J］. Advanced Drug Delivery Reviews, 2008, 60(15): 1627-1637.

[22] HARDMAN R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors［J］. Environmental Health Perspectives, 2006, 114(2): 165-172.

[23] YE L, YONG K T, LIU L, et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots［J］. Nature Nanotechnology, 2012, 7(7): 453-458.

洪旭亮, 王健, 陈丽, 林柏瀚, 熊建文. 基于量子点CdSe两次给药PDT体外灭活HL60的最佳参数实验研究[J]. 激光生物学报, 2013, 22(5): 416. HONG Xuliang, WANG Jian, CHEN Li, LIN Bohan, XIONG Jianwen. The Optimal Parameter of vitro Inactivation on Leukemic HL60 Cells by Double Drug Delivery of CdSe Quantum Dots Based on Photodynamic Therapy[J]. Acta Laser Biology Sinica, 2013, 22(5): 416.

基于量子点CdSe两次给药PDT体外灭活HL60的最佳参数实验研究

关于本站 Cookie 的使用提示

全站搜索

基于量子点CdSe两次给药PDT体外灭活HL60的最佳参数实验研究

相关论文

相关资讯

关于本站 Cookie 的使用提示

全站搜索